{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T15:04:28Z","timestamp":1780931068976,"version":"3.54.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,8]]},"DOI":"10.7759\/cureus.110457","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T14:45:39Z","timestamp":1780929939000},"source":"Crossref","is-referenced-by-count":0,"title":["Patient-Reported Flare Symptoms Following COVID-19 Vaccination in Systemic Lupus Erythematosus"],"prefix":"10.7759","author":[{"given":"Pannipa","family":"Bupparenoo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kittiwan","family":"Sumethkul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungchai","family":"Aungthararak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-020-00562-2","article-title":"Rheumatic disease and COVID-19: epidemiology and outcomes","volume":"17","author":"Hyrich KL","year":"2021","unstructured":"Hyrich KL, Machado PM. Rheumatic disease and COVID-19: epidemiology and outcomes. Nat Rev Rheumatol. 2021, 17:71-2. 10.1038\/s41584-020-00562-2","journal-title":"Nat Rev Rheumatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/art.41619","article-title":"COVID-19 outcomes in patients with systemic autoimmune rheumatic diseases compared to the general population: a US multicenter, comparative cohort study","volume":"73","author":"D'Silva KM","year":"2021","unstructured":"D'Silva KM, Jorge A, Cohen A, McCormick N, Zhang Y, Wallace ZS, Choi HK. COVID-19 outcomes in patients with systemic autoimmune rheumatic diseases compared to the general population: a US multicenter, comparative cohort study. Arthritis Rheumatol. 2021, 73:914-20. 10.1002\/art.41619","journal-title":"Arthritis Rheumatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(20)30227-7","article-title":"COVID-19 in patients with rheumatic disease in Hubei province, China: a multicentre retrospective observational study","volume":"2","author":"Zhong J","year":"2020","unstructured":"Zhong J, Shen G, Yang H, et al.. COVID-19 in patients with rheumatic disease in Hubei province, China: a multicentre retrospective observational study. Lancet Rheumatol. 2020, 2:e557-64. 10.1016\/S2665-9913(20)30227-7","journal-title":"Lancet Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102778","article-title":"Clinical outcomes of COVID-19 in patients with rheumatic diseases: A systematic review and meta-analysis of global data","volume":"20","author":"Xu C","year":"2021","unstructured":"Xu C, Yi Z, Cai R, Chen R, Thong BY, Mu R. Clinical outcomes of COVID-19 in patients with rheumatic diseases: A systematic review and meta-analysis of global data. Autoimmun Rev. 2021, 20:102778. 10.1016\/j.autrev.2021.102778","journal-title":"Autoimmun Rev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2021.36.e95","article-title":"COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: clinical guidance of the Korean College of Rheumatology","volume":"36","author":"Park JK","year":"2021","unstructured":"Park JK, Lee EB, Shin K, et al.. COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: clinical guidance of the Korean College of Rheumatology. J Korean Med Sci. 2021, 36:e95. 10.3346\/jkms.2021.36.e95","journal-title":"J Korean Med Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.14107","article-title":"Recommendations for COVID-19 vaccination in people with rheumatic disease: Developed by the Singapore Chapter of Rheumatologists","volume":"24","author":"Santosa A","year":"2021","unstructured":"Santosa A, Xu C, Arkachaisri T, et al.. Recommendations for COVID-19 vaccination in people with rheumatic disease: Developed by the Singapore Chapter of Rheumatologists. Int J Rheum Dis. 2021, 24:746-57. 10.1111\/1756-185X.14107","journal-title":"Int J Rheum Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00393-021-01055-7","article-title":"Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV-2\/COVID-19 pandemic, including recommendations for COVID-19 vaccination","volume":"80","author":"Specker C","year":"2021","unstructured":"Specker C, Aries P, Braun J, et al.. Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV-2\/COVID-19 pandemic, including recommendations for COVID-19 vaccination. Z Rheumatol. 2021, 80:33-48. 10.1007\/s00393-021-01055-7","journal-title":"Z Rheumatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/art.42372","article-title":"American College of Rheumatology guidance for COVID-19 vaccination in patients with rheumatic and musculoskeletal diseases: version 5","volume":"75","author":"Curtis JR","year":"2023","unstructured":"Curtis JR, Johnson SR, Anthony DD, et al.. American College of Rheumatology guidance for COVID-19 vaccination in patients with rheumatic and musculoskeletal diseases: version 5. Arthritis Rheumatol. 2023, 75:E1-16. 10.1002\/art.42372","journal-title":"Arthritis Rheumatol"},{"key":"ref9","article-title":"Recommendations for COVID-19 vaccination in patients with rheumatic diseases (article iin Thai)","author":"Thai Rheumatism Association","year":"2021","unstructured":"Thai Rheumatism Association. Recommendations for COVID-19 vaccination in patients with rheumatic diseases (article iin Thai). Thai J Rheumatol. 2021, 1-3.","journal-title":"Thai J Rheumatol"},{"key":"ref10","unstructured":"Interim Clinical Considerations for Use of COVID-19 Vaccines in the United States. (2025). Accessed. June 7, 2026: https:\/\/www.cdc.gov\/covid\/hcp\/vaccine-considerations\/index.html."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-220647","article-title":"Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study","volume":"80","author":"Furer V","year":"2021","unstructured":"Furer V, Eviatar T, Zisman D, et al.. Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study. Ann Rheum Dis. 2021, 80:1330-8. 10.1136\/annrheumdis-2021-220647","journal-title":"Ann Rheum Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(21)00039-4","article-title":"Vaccination against COVID-19: expectations and concerns of patients with autoimmune and rheumatic diseases","volume":"3","author":"Felten R","year":"2021","unstructured":"Felten R, Dubois M, Ugarte-Gil MF, et al.. Vaccination against COVID-19: expectations and concerns of patients with autoimmune and rheumatic diseases. Lancet Rheumatol. 2021, 3:E243-5. 10.1016\/S2665-9913(21)00039-4","journal-title":"Lancet Rheumatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2022.08.068","article-title":"Hesitancy for SARS-CoV-2 vaccines and post-vaccination flares in patients with systemic lupus erythematosus","volume":"40","author":"Mok CC","year":"2022","unstructured":"Mok CC, Chan KL, Tse SM. Hesitancy for SARS-CoV-2 vaccines and post-vaccination flares in patients with systemic lupus erythematosus. Vaccine. 2022, 40:5959-64. 10.1016\/j.vaccine.2022.08.068","journal-title":"Vaccine"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/acr.25288","article-title":"Association of COVID-19 vaccinations with flares of systemic rheumatic disease: a case-crossover study","volume":"76","author":"Braverman G","year":"2024","unstructured":"Braverman G, Barbhaiya M, Nong M, Bykerk VP, Hupert N, Lewis C 5th, Mandl LA. Association of COVID-19 vaccinations with flares of systemic rheumatic disease: a case-crossover study. Arthritis Care Res (Hoboken). 2024, 76:733-42. 10.1002\/acr.25288","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(21)00221-6","article-title":"Tolerance of COVID-19 vaccination in patients with systemic lupus erythematosus: the international VACOLUP study","volume":"3","author":"Felten R","year":"2021","unstructured":"Felten R, Kawka L, Dubois M, Ugarte-Gil MF, Fuentes-Silva Y, Piga M, Arnaud L. Tolerance of COVID-19 vaccination in patients with systemic lupus erythematosus: the international VACOLUP study. Lancet Rheumatol. 2021, 3:e613-15. 10.1016\/S2665-9913(21)00221-6","journal-title":"Lancet Rheumatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1177\/09612033231151898","article-title":"Short- and mid-term outcomes in systemic lupus erythematosus patients presenting with disease exacerbation after SARS-CoV-2 mRNA vaccination: a cohort study from Puerto Rico","volume":"32","author":"Gonz\u00e1lez-Mel\u00e9ndez A","year":"2023","unstructured":"Gonz\u00e1lez-Mel\u00e9ndez A, B\u00e1ez-Negr\u00f3n L, R\u00edos-Rivera R, Franco-O'Connell AS, Nieves-Plaza M, Vil\u00e1 LM. Short- and mid-term outcomes in systemic lupus erythematosus patients presenting with disease exacerbation after SARS-CoV-2 mRNA vaccination: a cohort study from Puerto Rico. Lupus. 2023, 32:571-9. 10.1177\/09612033231151898","journal-title":"Lupus"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/art.41937","article-title":"Evaluation of immune response and disease status in systemic lupus erythematosus patients following SARS-CoV-2 vaccination","volume":"74","author":"Izmirly PM","year":"2022","unstructured":"Izmirly PM, Kim MY, Samanovic M, et al.. Evaluation of immune response and disease status in systemic lupus erythematosus patients following SARS-CoV-2 vaccination. Arthritis Rheumatol. 2022, 74:284-94. 10.1002\/art.41937","journal-title":"Arthritis Rheumatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg MC","year":"1997","unstructured":"Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997, 40:1725. 10.1002\/art.1780400928","journal-title":"Arthritis Rheum"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri M","year":"2012","unstructured":"Petri M, Orbai AM, Alarc\u00f3n GS, et al.. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012, 64:2677-86. 10.1002\/art.34473","journal-title":"Arthritis Rheum"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/art.40930","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"71","author":"Aringer M","year":"2019","unstructured":"Aringer M, Costenbader K, Daikh D, et al.. 2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol. 2019, 71:1400-12. 10.1002\/art.40930","journal-title":"Arthritis Rheumatol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.31138\/mjr.28.1.4","article-title":"Flares in systemic lupus erythematosus: diagnosis, risk factors and preventive strategies","volume":"28","author":"Adamichou C","year":"2017","unstructured":"Adamichou C, Bertsias G. Flares in systemic lupus erythematosus: diagnosis, risk factors and preventive strategies. Mediterr J Rheumatol. 2017, 28:4-12. 10.31138\/mjr.28.1.4","journal-title":"Mediterr J Rheumatol"},{"key":"ref22","article-title":"The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus","volume":"31","author":"Uribe AG","year":"2004","unstructured":"Uribe AG, Vila LM, McGwin G, Jr, Sanchez ML, Reveille JD, Alarcon GS. The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus. J Rheumatol. 2004, 31:1934-40.","journal-title":"J Rheumatol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209519","article-title":"A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)","volume":"76","author":"van Vollenhoven R","year":"2017","unstructured":"van Vollenhoven R, Voskuyl A, Bertsias G, et al.. A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS). Ann Rheum Dis. 2017, 76:554-61. 10.1136\/annrheumdis-2016-209519","journal-title":"Ann Rheum Dis"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211814","article-title":"Remission and Low Disease Activity Status (LDAS) protect lupus patients from damage occurrence: data from a multiethnic, multinational Latin American Lupus Cohort (GLADEL)","volume":"76","author":"Ugarte-Gil MF","year":"2017","unstructured":"Ugarte-Gil MF, Wojdyla D, Pons-Estel GJ, et al.. Remission and Low Disease Activity Status (LDAS) protect lupus patients from damage occurrence: data from a multiethnic, multinational Latin American Lupus Cohort (GLADEL). Ann Rheum Dis. 2017, 76:2071-4. 10.1136\/annrheumdis-2017-211814","journal-title":"Ann Rheum Dis"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-021-05963-6","article-title":"Adverse events and disease flares after SARS-CoV-2 vaccination in patients with systemic lupus erythematosus","volume":"41","author":"Barbhaiya M","year":"2022","unstructured":"Barbhaiya M, Levine JM, Siegel CH, Bykerk VP, Jannat-Khah D, Mandl LA. Adverse events and disease flares after SARS-CoV-2 vaccination in patients with systemic lupus erythematosus. Clin Rheumatol. 2022, 41:1619-22. 10.1007\/s10067-021-05963-6","journal-title":"Clin Rheumatol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1080\/25785826.2023.2300163","article-title":"Risk of disease flares after SARS-CoV-2 mRNA vaccination in patients with systemic lupus erythematosus","volume":"47","author":"Kikuchi J","year":"2024","unstructured":"Kikuchi J, Kondo Y, Kojima S, et al.. Risk of disease flares after SARS-CoV-2 mRNA vaccination in patients with systemic lupus erythematosus. Immunol Med. 2024, 47:76-84. 10.1080\/25785826.2023.2300163","journal-title":"Immunol Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12121399","article-title":"Flares and predicting factors of flares in patients with systemic lupus erythematosus associated with different doses and types of COVID-19 vaccines","volume":"12","author":"Louthrenoo W","year":"2024","unstructured":"Louthrenoo W, Tangkum P, Kasitanon N, Gumtorntip W, Winichakoon P, Konsamun S, Wongthanee A. Flares and predicting factors of flares in patients with systemic lupus erythematosus associated with different doses and types of COVID-19 vaccines. Vaccines (Basel). 2024, 12:1399. 10.3390\/vaccines12121399","journal-title":"Vaccines (Basel)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/501574-patient-reported-flare-symptoms-following-covid-19-vaccination-in-systemic-lupus-erythematosus","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T14:45:43Z","timestamp":1780929943000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/501574-patient-reported-flare-symptoms-following-covid-19-vaccination-in-systemic-lupus-erythematosus"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.110457","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,8]]}}}